|
End-of-day quote
Taiwan S.E.
29/10/2026
|
5-day change | 1st Jan Change | ||
| 49.00 TWD | +1.24% |
|
-0.71% | -20.58% |
| 10-07 | EirGenix Submits European Marketing Application for Breast Cancer Biosimilar | MT |
| 09-10 | EirGenix Completes Capital Reduction Following RSA Write-Off | MT |
| Market Cap | 14.63B 449M 402M 371M 336M 628M 42.76B 638M 4.43B 1.77B 22.38B 1.69B 1.65B 70.88B | P/E 2026 * |
-32.2x | P/E 2027 * | 86x |
|---|---|---|---|---|---|
| Enterprise Value | 13.39B 411M 368M 339M 307M 574M 39.12B 584M 4.05B 1.62B 20.47B 1.54B 1.51B 64.84B | EV / Sales 2026 * |
9.08x | EV / Sales 2027 * | 5.89x |
| Free-Float |
59.34% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +1.24% | ||
| 1 week | -0.71% | ||
| Current month | -8.24% | ||
| 1 month | -4.67% | ||
| 3 months | +6.64% | ||
| 6 months | +2.83% | ||
| Current year | -20.58% |
| 1 week | 48.15 |  | 50.1 |
| 1 month | 48.15 | | 54 |
| Current year | 40.15 | | 67.6 |
| 1 year | 40.15 | | 84.3 |
| 3 years | 40.15 | | 111 |
| 5 years | 40.15 | | 163.5 |
| 10 years | 21.55 | | 195 |
| Manager | Title | Age | Since |
|---|---|---|---|
Li Cheng Liu
CEO | Chief Executive Officer | - | 01/04/2013 |
Hsiu Chuan Yang
DFI | Director of Finance/CFO | - | 03/05/2016 |
Yu Wen Liu
PRN | Corporate Officer/Principal | - | 20/05/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Cheng Yue Cheng
BRD | Director/Board Member | - | 14/06/2013 |
Hsiu Hui Chen
BRD | Director/Board Member | - | 13/09/2016 |
Li Cheng Liu
CHM | Chairman | - | 10/06/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.24% | -0.71% | -26.97% | -53.77% | 445M | |
| +6.63% | +8.10% | +67.50% | +145.20% | 1,148B | |
| +1.53% | +6.76% | +47.22% | +89.01% | 652B | |
| +1.68% | +2.10% | +27.80% | +109.31% | 505B | |
| +0.73% | +2.47% | +53.85% | +68.96% | 384B | |
| +3.83% | -2.37% | +68.14% | +42.32% | 348B | |
| +2.38% | +4.27% | +33.81% | +57.95% | 294B | |
| +2.26% | +3.47% | +5.21% | +28.92% | 264B | |
| +1.97% | +5.11% | +57.74% | +76.14% | 244B | |
| +4.03% | +7.84% | +40.49% | +116.14% | 197B | |
| Average | +2.23% | +1.18% | +37.48% | +68.02% | 403.76B | |
| Weighted average by Cap. | +2.25% | +1.50% | +49.57% | +95.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.47B 45.23M 40.51M 37.37M 33.82M 63.24M 4.31B 64.26M 446M 178M 2.25B 170M 166M 7.14B | 2.34B 71.89M 64.39M 59.41M 53.76M 101M 6.85B 102M 709M 283M 3.58B 270M 264M 11.35B |
| Net income | -458M -14.05M -12.59M -11.61M -10.51M -19.65M -1.34B -19.97M -139M -55.27M -700M -52.74M -51.62M -2.22B | 172M 5.28M 4.73M 4.36M 3.95M 7.38M 503M 7.5M 52.03M 20.76M 263M 19.81M 19.38M 833M |
| Net Debt | -1.25B -38.26M -34.27M -31.62M -28.61M -53.5M -3.64B -54.37M -377M -150M -1.91B -144M -141M -6.04B | -838M -25.71M -23.03M -21.25M -19.23M -35.95M -2.45B -36.54M -253M -101M -1.28B -96.5M -94.44M -4.06B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | NT$49.00 | +1.24% | 404,700 |
| 28/10/26 | NT$48.40 | -0.82% | 414,039 |
| 27/10/26 | NT$48.80 | -1.81% | 333,450 |
| 22/10/26 | NT$49.70 | +0.71% | 290,030 |
| 21/10/26 | NT$49.35 | +0.51% | 232,203 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6589 Stock
Select your edition
All financial news and data tailored to specific country editions
